CE–MS-based urinary biomarkers to distinguish non-significant from significant prostate cancer

BACKGROUND: Prostate cancer progresses slowly when present in low risk forms but can be lethal when it progresses to metastatic disease. A non-invasive test that can detect significant prostate cancer is needed to guide patient management. METHODS: Capillary electrophoresis/mass spectrometry has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Frantzi, Maria, Gomez Gomez, Enrique, Blanca Pedregosa, Ana, Valero Rosa, José, Latosinska, Agnieszka, Culig, Zoran, Merseburger, Axel S., Luque, Raul M., Requena Tapia, María José, Mischak, Harald, Carrasco Valiente, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738044/
https://www.ncbi.nlm.nih.gov/pubmed/31092909
http://dx.doi.org/10.1038/s41416-019-0472-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738044/
https://www.ncbi.nlm.nih.gov/pubmed/31092909
http://dx.doi.org/10.1038/s41416-019-0472-z

Ejemplares similares